Changchun High & New Technology Industry Group

Changchun High & New Technology Industry Group is a prominent Chinese biopharmaceutical conglomerate that operates as a holding company for several high-growth life science subsidiaries. The group's primary value driver is GeneScience Pharmaceuticals (GenSci), the leading provider of recombinant human growth hormone in China, offering both short-acting and long-acting formulations. Another key subsidiary, BCHT Biotech, specializes in the development and commercialization of vaccines, including those for varicella, rabies, and shingles. With a strong focus on endocrinology, infectious diseases, and oncology, the group maintains a dominant market position in the Chinese pediatric growth market while expanding its footprint in women's health and high-end biologics.